Ipsen Pharma

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
>
Registration as it was on 17 Oct 2022
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

100,000€ - 199,999€

Financial year: Jan 2021 - Dec 2021

Lobbyists (Full time equivalent)

0.2 Fte (2)

Lobbyists with EP accreditation

1

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Ipsen Pharma

    EU Transparency Register

    84295189159-07 First registered on 15 Jul 2012

    Goals / Remit

    Ipsen is a leading biopharmaceutical group dedicated to improving lives through innovative medicines in oncology, neuroscience and rare diseases.

    Main EU files targeted

    Medicinal products for human use
    Research and Development in life sciences
    Horizon Europe
    Intellectual Property Rights
    Pharmaceutical Incentives
    Brexit
    European Green Deal
    Industry Strategy
    Pharmaceutical Strategy
    Europe's Beating Cancer Plan
    European Health Technology Assessment
    Multiannual Financial Framework
    EU Trade Agreements

    Address

    Head Office
    65, quai Georges Gorse
    Boulogne-Billancourt 92650
    FRANCE
    EU Office
    Square de Meeus
    Brussels 1000
    BELGIUM

    Website

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    10%2

    Lobbyists (Full time equivalent)

    0.2

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    1 accreditations were / are live (in bold) for the selected state of 29 Nov 2022

    Name Start date End Date
    Ms Loubna Ouriaghli 18 Oct 2022 13 Oct 2023
    Ms Heloise LEVALLOIS 14 Sep 2019 11 Sep 2020
    Mr Jan SWIDERSKI 24 May 2018 23 May 2019
    Ms Heloise LEVALLOIS 28 Apr 2018 26 Apr 2019
    Ms Heloise LEVALLOIS 15 Sep 2016 14 Sep 2017
    Mr Giovanni Asta 06 Sep 2016 06 Sep 2017
    Mr Jan SWIDERSKI 05 Sep 2016 31 Aug 2017
    Ms Heloise LEVALLOIS 10 Sep 2015 08 Sep 2016
    Mr Giovanni Asta 17 Jul 2015 15 Jul 2016
    Mr Jan SWIDERSKI 17 Jul 2015 15 Jul 2016
    Mr Giovanni Asta 05 Jul 2014 03 Jul 2015
    Mr Jan SWIDERSKI 28 Jun 2014 26 Jun 2015

    Complementary Information

    2 Ipsen employees spend less than 10% of their time on activities covered by the Register.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Ipsen Pharma is a member of several organisations that may engage in activities covered by the Register:
    - IFPMA
    - EFPIA
    - EuropaBio
    - EBE
    - PhRMA
    - G5 Santé

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2021 - Dec 2021

    Lobbying costs for closed financial year

    100,000€ - 199,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    100,000€ - 199,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

Download this datacard